The Central Political Bureau meeting held at the end of April emphasized the need to actively develop venture capital and strengthen patient capital. In the current context of accelerating the cultivation and development of new quality productive forces, emphasizing the importance of strengthening patient capital is of great significance. Patient capital refers to capital that can withstand short-term fluctuations, is not eager to achieve results, and pursues long-term stable returns. Based on long-term investment profitability considerations, patient capital will not easily change its strategy due to short-term market fluctuations. This can play a stabilizing role in the market, significantly reduce capital market volatility, enhance market stability and risk resistance, and promote stable and healthy development of the capital market. Especially in today's world where economic fluctuations are intensifying and technological competition is becoming increasingly fierce, achieving technological self-reliance and accelerating the development of new productive forces requires long-term stable financial support with strategic determination. Strengthening patient capital is a systematic project. In recent years, the conditions for China's capital market to serve high-level technological self-reliance and self-improvement have become more complete and the foundation has become more solid. The release of the new "National Nine Articles" and its supporting policies has laid a solid foundation for the development of patient capital. The Central Political Bureau meeting proposed to "strengthen patient capital", which is of great significance for the high-quality development of the capital market and the development of new productive forces. We need to expand the source of patient capital. Actively introduce medium - and long-term funds, such as social security funds, insurance funds, pension funds, enterprise annuities, venture capital funds, industry funds, government guidance funds, and funds from various parties involved in long-term investment. According to the nature of funds, increase the weight and scale of equity asset allocation, optimize the long-term investment structure, so that patient capital of different natures can find matching scenarios in the capital market and share the dividends of economic development. We should guide patient capital to increase investment in science and technology innovation oriented small and medium-sized enterprises. In terms of institutional construction, relevant departments should scientifically plan and systematically support, improve the policy environment conducive to the entry of medium and long-term funds into the market, including guiding various institutions to implement long-term assessments, providing tax incentives, financial support, etc., and guiding the venture capital industry to invest in early, small, and hard technology. Patience capital is not about not considering investment returns, but about extending the evaluation cycle, planning the early stages of projects in advance, and seizing the growth potential of the enterprise. This means that in the primary market, relevant institutions should support patient capital to sink into earlier investment stages or more segmented professional tracks to discover value, invest in true innovation, and avoid pseudo innovation; In the secondary market, it is necessary to guide funds to patiently become "friends of time", strengthen institutional countercyclical layout, invest in true value, and avoid concept speculation. Overall, it is necessary to build a funding chain around the innovation chain and industrial chain, improve the multi-level rocket supporting innovative development, and provide a patient capital network at different growth stages of science and technology innovation enterprises to match the innovation cycle of new productive forces from sowing to growing into towering trees. Strengthening patient capital will not be achieved overnight, and multiple measures need to be taken simultaneously to form a joint force. When patient capital gives patience to the market, the market gives confidence to science and technology innovation, and science and technology innovation feeds back to the market, a virtuous cycle of "technology industry finance" can be formed, achieving mutual prosperity and symbiosis. (Lai Xin She)